{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-296600","form_type":"8-K","ticker":null,"cik":"0001799850","company_name":"Renovacor, Inc.","filed_at":"2022-12-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:52.165379+00:00","generated_at":"2026-06-21T11:05:48.400660+00:00","sec_items":["2.01","3.01","3.03","5.01","5.02","5.03","5.07","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Renovacor acquired by Rocket Pharmaceuticals; shareholders to receive 0.1763 Rocket shares per share","bullets":["Acquisition closed Dec 1, 2022; each Renovacor share converted into 0.1763 Rocket shares.","Renovacor delisted from NYSE American; reporting obligations to be terminated via Form 15.","All directors (Gbola Amusa, Edward Benz, etc.) and officers resigned effective at closing.","Stockholders voted overwhelmingly to adopt the merger: 14,716,307 for, 1,000 against.","Company becomes wholly owned subsidiary of Rocket Pharmaceuticals."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-296600","json":"https://secwatch.observer/filing/0001193125-22-296600.json","markdown":"https://secwatch.observer/filing/0001193125-22-296600.md","text":"https://secwatch.observer/filing/0001193125-22-296600.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1799850/000119312522296600/0001193125-22-296600-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1799850/000119312522296600/d256474d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T11:05:48.400660+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"086e2e2e6e","claim":"Marc Semigran, M.D. departed as other at Renovacor, Inc..","evidence_excerpt":"each of Magdalene Cook, M.D., Marc Semigran, M.D., Joseph Carroll, Matthew Killeen, Ph.D., and Wendy DiCicco ceased to be officers of Renovacor and its subsidiaries","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1799850/000119312522296600/0001193125-22-296600-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased"}],"fact_type":"executive_change"},{"claim_id":"0a35147e3f","claim":"Jonas Grossman resigned as Director at Renovacor, Inc..","evidence_excerpt":"the resignations of Gbola Amusa, M.D, Edward J. Benz, Jr., Magdalene Cook, M.D., Gregory F. Covino, Jonas Grossman, Joan Lau, Ph.D., and Thomas Needham from the board of directors of Renovacor and any committees thereof became effective","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1799850/000119312522296600/0001193125-22-296600-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"1540d38910","claim":"Magdalene Cook, M.D. departed as other at Renovacor, Inc..","evidence_excerpt":"each of Magdalene Cook, M.D., Marc Semigran, M.D., Joseph Carroll, Matthew Killeen, Ph.D., and Wendy DiCicco ceased to be officers of Renovacor and its subsidiaries","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1799850/000119312522296600/0001193125-22-296600-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased"}],"fact_type":"executive_change"},{"claim_id":"16362de185","claim":"Wendy DiCicco departed as other at Renovacor, Inc..","evidence_excerpt":"each of Magdalene Cook, M.D., Marc Semigran, M.D., Joseph Carroll, Matthew Killeen, Ph.D., and Wendy DiCicco ceased to be officers of Renovacor and its subsidiaries","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1799850/000119312522296600/0001193125-22-296600-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased"}],"fact_type":"executive_change"},{"claim_id":"1735186f4e","claim":"Joan Lau, Ph.D. resigned as Director at Renovacor, Inc..","evidence_excerpt":"the resignations of Gbola Amusa, M.D, Edward J. Benz, Jr., Magdalene Cook, M.D., Gregory F. Covino, Jonas Grossman, Joan Lau, Ph.D., and Thomas Needham from the board of directors of Renovacor and any committees thereof became effective","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1799850/000119312522296600/0001193125-22-296600-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"5d8ced9ead","claim":"Gbola Amusa, M.D. resigned as Director at Renovacor, Inc..","evidence_excerpt":"the resignations of Gbola Amusa, M.D, Edward J. Benz, Jr., Magdalene Cook, M.D., Gregory F. Covino, Jonas Grossman, Joan Lau, Ph.D., and Thomas Needham from the board of directors of Renovacor and any committees thereof became effective","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1799850/000119312522296600/0001193125-22-296600-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"b427985ce6","claim":"Matthew Killeen, Ph.D. departed as other at Renovacor, Inc..","evidence_excerpt":"each of Magdalene Cook, M.D., Marc Semigran, M.D., Joseph Carroll, Matthew Killeen, Ph.D., and Wendy DiCicco ceased to be officers of Renovacor and its subsidiaries","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1799850/000119312522296600/0001193125-22-296600-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased"}],"fact_type":"executive_change"},{"claim_id":"be6fe811d9","claim":"Gregory F. Covino resigned as Director at Renovacor, Inc..","evidence_excerpt":"the resignations of Gbola Amusa, M.D, Edward J. Benz, Jr., Magdalene Cook, M.D., Gregory F. Covino, Jonas Grossman, Joan Lau, Ph.D., and Thomas Needham from the board of directors of Renovacor and any committees thereof became effective","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1799850/000119312522296600/0001193125-22-296600-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"e1fccd7f83","claim":"Thomas Needham resigned as Director at Renovacor, Inc..","evidence_excerpt":"the resignations of Gbola Amusa, M.D, Edward J. Benz, Jr., Magdalene Cook, M.D., Gregory F. Covino, Jonas Grossman, Joan Lau, Ph.D., and Thomas Needham from the board of directors of Renovacor and any committees thereof became effective","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1799850/000119312522296600/0001193125-22-296600-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"e8757666b2","claim":"Joseph Carroll departed as other at Renovacor, Inc..","evidence_excerpt":"each of Magdalene Cook, M.D., Marc Semigran, M.D., Joseph Carroll, Matthew Killeen, Ph.D., and Wendy DiCicco ceased to be officers of Renovacor and its subsidiaries","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1799850/000119312522296600/0001193125-22-296600-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased"}],"fact_type":"executive_change"},{"claim_id":"eb9c45414c","claim":"Edward J. Benz, Jr. resigned as Director at Renovacor, Inc..","evidence_excerpt":"the resignations of Gbola Amusa, M.D, Edward J. Benz, Jr., Magdalene Cook, M.D., Gregory F. Covino, Jonas Grossman, Joan Lau, Ph.D., and Thomas Needham from the board of directors of Renovacor and any committees thereof became effective","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1799850/000119312522296600/0001193125-22-296600-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"fd62f07bab","claim":"Magdalene Cook, M.D. resigned as Director at Renovacor, Inc..","evidence_excerpt":"the resignations of Gbola Amusa, M.D, Edward J. Benz, Jr., Magdalene Cook, M.D., Gregory F. Covino, Jonas Grossman, Joan Lau, Ph.D., and Thomas Needham from the board of directors of Renovacor and any committees thereof became effective","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1799850/000119312522296600/0001193125-22-296600-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"4842e7b4c4adab883e4bb3ffce8e0525f766fea1","claim":"Renovacor, Inc.: Amendments to articles of incorporation and bylaws as part of merger, subject to certain changes per merger agreement.","evidence_excerpt":"Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. In connection with the consummation of the First Merger and pursuant to the Merger Agreement, (a) at the First Effective Time, the Second Amended and Restated Certificate of Incorporation, as amended, and the Bylaws of Renovacor, as in effect immediately prior to the First Effective Time, continued to be the certificate of incorporation and bylaws of Renovacor, as the surviving corporation in the First Merger, and (b) at the Second Effective Time, the Certificate of Formation and Limited Liability Company Agreement of Merger Sub II in effect immediately prior to the Second Effective Time continued to be the certificate of formation and limited liability company agreement of Merger Sub II, as the Surviving Company in the Second Merger (and thereby became the Certificate of Formation and Limited Liability Company Agreement of the Company pursuant to the Second Merger), subject to certain changes as provid","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1799850/000119312522296600/0001193125-22-296600-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"}],"fact_type":"governance_change"},{"claim_id":"b469048d450e5351299bd4ae129a5cba8d3c8dea","claim":"Renovacor, Inc. completed an acquisition involving Rocket Pharmaceuticals, Inc. for 0.1763 shares of Rocket common stock per share of Renovacor common stock, with adjustments for net cash and treatment of options, warrants, and RSUs. (closed 2022-12-01).","evidence_excerpt":"(“ Company Shares ”) outstanding immediately prior to the effective time of the First Merger (the “ First Effective Time ”) were canceled and converted into the right to receive 0.1763 fully paid and non-assessable shares of Parent common stock, $0.01 par value per share (“ Parent Shares ”), which was determined on the basis of an exchange formula set forth in","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1799850/000119312522296600/0001193125-22-296600-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"acquisition"},{"label":"Counterparty","value":"Rocket Pharmaceuticals, Inc."},{"label":"Consideration","value":"0.1763 shares of Rocket common stock per share of Renovacor common stock, with adjustments for net cash and treatment of options, warrants, and RSUs."},{"label":"Closing","value":"2022-12-01"}],"fact_type":"ma_transaction"},{"claim_id":"320fdc17b49bbace52c6ead0b8bb7823816837a8","claim":"Renovacor, Inc. shareholders approved To adopt the Merger Agreement and thereby approve the First Merger and other transactions contemplated thereby at the 2022-11-30 meeting.","evidence_excerpt":"Proposal 1: To adopt the Merger Agreement and thereby approve the First Merger and other transactions contemplated thereby: For Against Abstentions 14,716,307 1,000 3","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1799850/000119312522296600/0001193125-22-296600-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"merger approval"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2022-11-30"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}